IL18R1 expression also correlates with inflammation and high NLR (neutrophil/lymphocyte ratio) in melanoma (Mallardo et al., 2023), which validated the prognostic role of the inflammatory gene signature in addition to hematopoietic malignancies. The gene discussed is IL18R1; the disease is melanoma.